Healthcare provider profile · identity verified

Pawel Olszewski, MD

Internal Medicine · BELOIT, WI · NPI 1679582043

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	528	141
Amlodipine Besylate	Amlodipine Besylate	491	134
Lisinopril	Lisinopril	432	120
Levothyroxine Sodium	Levothyroxine Sodium	345	79
Metoprolol Succinate	Metoprolol Succinate	299	75
Omeprazole	Omeprazole	295	76
Losartan Potassium	Losartan Potassium	281	75
Metformin Hcl	Metformin Hcl	251	70
Hydrochlorothiazide	Hydrochlorothiazide	246	66
Rosuvastatin Calcium	Rosuvastatin Calcium	222	64
Furosemide	Furosemide	218	55
Eliquis	Apixaban	167	36
Sertraline Hcl	Sertraline Hcl	149	36
Simvastatin	Simvastatin	147	35
Pravastatin Sodium	Pravastatin Sodium	146	34
Metoprolol Tartrate	Metoprolol Tartrate	144	36
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	140	28
Allopurinol	Allopurinol	136	33
Albuterol Sulfate Hfa	Albuterol Sulfate	130	60
Gabapentin	Gabapentin	128	29
Glimepiride	Glimepiride	126	34
Pantoprazole Sodium	Pantoprazole Sodium	113	29
Potassium Chloride	Potassium Chloride	104	24
Citalopram Hbr	Citalopram Hydrobromide	99	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	95	26
Tamsulosin Hcl	Tamsulosin Hcl	95	25
Glipizide Er	Glipizide	86	20
Chlorthalidone	Chlorthalidone	84	18
Lorazepam	Lorazepam	82	21
Alprazolam	Alprazolam	81	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	81	22
Quetiapine Fumarate	Quetiapine Fumarate	79	11
Atenolol	Atenolol	77	20
Ezetimibe	Ezetimibe	74	19
Warfarin Sodium	Warfarin Sodium	74	20
Hydralazine Hcl	Hydralazine Hcl	73	21
Trazodone Hcl	Trazodone Hcl	72	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	71	63
Azithromycin	Azithromycin	65	61
Fluticasone Propionate	Fluticasone Propionate	64	26
Clopidogrel	Clopidogrel Bisulfate	63	17
Olmesartan Medoxomil	Olmesartan Medoxomil	63	18
Mirtazapine	Mirtazapine	56	suppressed
Tramadol Hcl	Tramadol Hcl	55	15
Carvedilol	Carvedilol	54	15
Methylprednisolone	Methylprednisolone	53	52
Lovastatin	Lovastatin	52	13
Meloxicam	Meloxicam	51	17
Montelukast Sodium	Montelukast Sodium	51	14
Nifedipine Er	Nifedipine	50	11
Spironolactone	Spironolactone	50	13
Indapamide	Indapamide	47	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	46	16
Escitalopram Oxalate	Escitalopram Oxalate	46	16
Glipizide	Glipizide	45	11
Digoxin	Digoxin	44	suppressed
Prednisone	Prednisone	44	40
Benazepril Hcl	Benazepril Hcl	43	12
Ozempic	Semaglutide	43	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	42	39
Doxycycline Hyclate	Doxycycline Hyclate	42	41
Jardiance	Empagliflozin	39	12
Diazepam	Diazepam	38	suppressed
Donepezil Hcl	Donepezil Hcl	38	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Famotidine	Famotidine	36	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	34	suppressed
Cephalexin	Cephalexin	33	33
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	32	12
Zolpidem Tartrate	Zolpidem Tartrate	32	suppressed
Amoxicillin	Amoxicillin	31	19
Propranolol Hcl Er	Propranolol Hcl	31	suppressed
Duloxetine Hcl	Duloxetine Hcl	30	suppressed
Finasteride	Finasteride	30	suppressed
Amiodarone Hcl	Amiodarone Hcl	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	14
Entresto	Sacubitril/Valsartan	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Enalapril Maleate	Enalapril Maleate	26	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	26	suppressed
Arnuity Ellipta	Fluticasone Furoate	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Metformin Hcl Er	Metformin Hcl	22	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	21	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	21	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Colchicine	Colchicine	20	11
Humulin R	Insulin Regular, Human	20	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	20	suppressed
Klor-Con M20	Potassium Chloride	19	suppressed
Loperamide	Loperamide Hcl	19	suppressed
Bumetanide	Bumetanide	18	suppressed
Calcitriol	Calcitriol	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Verapamil Sr	Verapamil Hcl	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	16	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Matzim La	Diltiazem Hcl	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Sulfasalazine	Sulfasalazine	15	suppressed
Tiadylt Er	Diltiazem Hcl	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	12
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Ramipril	Ramipril	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	11
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Pregabalin	Pregabalin	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	12	11
Trulicity	Dulaglutide	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Cefdinir	Cefdinir	11	11
Irbesartan	Irbesartan	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error